Exercise may improve outcomes for patients with hematologic cancers

the ONA take:

A 12-week exercise rehabilitation program resulted in improvements in cancer-related fatigue and additional outcomes in patients with hematologic cancer following treatment, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.

Because patients with hematologic malignancies exhibit significant physical deconditioning and psychological distress after treatment, researchers sought to evaluate the efficacy of a 12-week exercise rehabilitation on cancer-related fatigue and related outcomes in these patients following treatment.

Researchers enrolled 37 patients and randomly assigned them 1:1 to participate in the 12-week exercise rehabilitation or usual care.

The rehabilitation consisted of tailored exercise programs comprising aerobic and resistance exercises performed three times weekly for 12 weeks in local gyms and clinics. Those in the usual care group were offered a delayed, tailored 12-week exercise program after the initial study period.

The study demonstrated that the 12-week exercise rehabilitation program resulted in significant improvement in cancer-related fatigue, cardiovascular fitness, quality of life, muscle strength, and body composition. The delayed 12-week exercise program also showed similar significant improvements in patient outcomes.

Teenage exercise may reduce risk of dying from cancer during adulthood in women
A 12-week exercise rehabilitation program resulted in improvements in cancer-related fatigue.
Following treatment, haematological cancer (HEM) patients exhibit significant physical deconditioning and psychological distress. Exercise has been shown as a clinically effective and safe intervention for cancer patients, with the potential to reverse the deleterious effects following treatment. Our aim was to investigate the efficacy of a 12-week exercise rehabilitation on cancer-related fatigue (CRF) and associated outcomes in HEM patients post-treatment.
READ FULL ARTICLE From Springer
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs